ADVI
  • About Us
  • People
  • Insights
    • Publications
    • 2024 Presidential Election
    • Cell and Gene
    • Inflation Reduction Act
    • Case Studies
    • Events
    • News
    • Videos
  • Solutions
    • Policy, Research, and Analysis
    • Market Access
    • Reimbursement
    • Strategic Analytics, Value and Economics
      • ADVI Databoard
  • Join Us
  • Get in Touch
Get in Touch

Specialty: Urology

In The News Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor + Novel Hormonal Therapy Combination Therapy
In The News Value of next generation sequencing (NGS) testing in advanced cancer patients
In The News Expert consensus recommendations for managing adverse events in patients with metastatic prostate cancer treated with poly (ADP-ribose) polymerase inhibitor (PARPi) + novel hormonal therapy (NHT) combination therapy
In The News Comprehensive Review on the Clinical Impact of Next-Generation Sequencing Tests for the Management of Advanced Cancer
In The News Systematic Review of Skeletal-Related Events in Prostate Cancer
In The News Measurement properties of the benign prostatic hyperplasia impact index in tadalafil studies
In The News Construct Validity of the Benign Prostatic Hyperplasia Impact Index
In The News Literature Review and Product Label Claim Review of PRO Measures for Benign Prostatic Hyperplasia
© 2025
ADVI
  • image description
  • image description
INNOVATE@advi.com 202.509.0760 1000 F St NW, Suite 650 Washington, DC 20004

Subscribe

to get the latest news and insights from ADVI Health